Ixmyelocel-T, mesenchymal stem cells and monocytes for dilated cardiomyopathy

Ixmyelocel-T is a mixture of a CD90+ mesenchymal stem cells and monocytes, specifically expanded by an automated cell-processing system from autologous bone marrow. Other cell types from the bone marrow are partially depleted. Treated cardiomyopathy patients benefit from increased septal thickening and effect on the stratum resulting in better patient outcome.